4516 Share Price Performance
JP¥3,667.00
441.00 (13.67%)
Price JP¥3,667.00
Share Pricen/a
Analysis Article • Aug 09
Nippon Shinyaku Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
4516 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Nippon Shinyaku Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 13, 2026
- 468.23
- 65.32%
- 17.50%
- 0%
About 4516
- Founded
- 1911
- Employees
- 2309
- CEO
- WebsiteView website
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Atthena Therapeutics, Inc. to develop ATSN-101 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and Regenex Bio Inc. to develop RGX-121 and RGX-111 for the treatment of mucopolysaccharidosis type I and II. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
